This study is in progress, not accepting new patients
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at UC Irvine
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Concert Pharmaceuticals
- ID
- NCT03898479
- Phase
- Phase 2/3 Alopecia Research Study
- Study Type
- Interventional
- Participants
- Expecting 1000 study participants
- Last Updated